Navigation Links
San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer

SAN DIEGO, March 16 /PRNewswire/ -- SpineMark CRO Management, a wholly-owned subsidiary of San Diego based SpineMark Corporation, recently signed an agreement with Ranier Technology, a Cambridge, England based spinal medical device manufacturer, to provide contract research support services for the Ranier CAdisc™-L clinical trial, a 3rd generation lumbar total disc replacement device for treatment of degenerative disc disease in the lumbar spine.  SpineMark CRO Management provides site recruitment including utilization of principal investigators from its network of sites, reimbursement strategy development, payor education, trial management, site training, patient recruitment, data management, monitoring, regulatory advice and general oversight to allow Ranier to effectively complete their FDA requirements for approval of new spinal devices.  

"The SpineMark CRO model provides intermediary third party oversight to ensure that the highest quality of monitoring, management and resources can be brought to bear for Ranier, as well as the patients and physicians participating in this trial," explains Marcy Rogers, President and CEO of SpineMark.

The CAdisc™-L design, materials and biomechanics represent a significant clinical advance in the treatment of degenerative disc disease in the lumbar spine.  

"I am delighted to be working with SpineMark. Their specialized dedication to clinical research in spine, their relationships, and their ability to manage various aspects of the US clinical trial process makes them a perfect fit for our study," explains Dr. Geoffrey Andrews, CEO of Ranier Technology.

SpineMark offers an international medical advisory board and access to SpineMark's network of leading physicians and surgeons across the country. The corporation is an expert in FDA regulations and protocol, offering site operations support and training, contract negotiation and financial management, regulatory and compliance oversight and marketing and media relations.  

For more information on SpineMark CRO Management visit

For more information on Ranier Technology Limited visit

SOURCE SpineMark Corporation

Back to top



SOURCE SpineMark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
2. PG500 Series Presented at the AACR Annual Meeting in San Diego
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
7. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
8. Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
9. California American Water Celebrates No Drugs Down the Drain Week in San Diego
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
Post Your Comments:
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):